Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-25

Clinical Trial Update: Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo) [NA]

View source ↗

Summary

A University of Michigan-led clinical trial is investigating and modulating central mu-opioid mechanisms in chronic migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Chronic Migraine | NA | Status: RECRUITING